Fred E Cohen Insider Trading $URGN UroGen Pharma Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Fred E Cohen.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).

Fred E Cohen in UroGen Pharma Ltd.

Trading Symbol: URGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Fred E Cohen: Director
Holdings: 15,000 shares
Latest Transaction: Jun 09 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Fred E Cohen in UroGen Pharma Ltd.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 09 2021	URGN	UroGen Pharma Ltd.	Cohen Fred E	Director	Option Exercise	A	17.98	10,000	179,800	10,000
Jun 10 2020	URGN	UroGen Pharma Ltd.	Cohen Fred E	Director	Option Exercise	A	28.24	10,000	282,400	10,000
Jun 05 2019	URGN	UroGen Pharma Ltd.	Cohen Fred E	Director	Option Exercise	A	34.83	10,000	348,300	10,000
Mar 22 2019	URGN	UroGen Pharma Ltd.	Cohen Fred E	Director	Option Exercise	M	16.99	15,000	254,850	25,000
Mar 22 2019	URGN	UroGen Pharma Ltd.	Cohen Fred E	Director	Buy	M	16.99	15,000	254,850	15,000	0 to 15 K

Page: 1